ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $889,548 | +66.2% | 248,477 | +71.3% | 0.00% | +100.0% |
| Q2 2023 | $535,098 | +2.6% | 145,013 | -8.0% | 0.00% | 0.0% |
| Q1 2023 | $521,583 | -17.4% | 157,578 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $631,264 | +76.8% | 162,697 | +10.7% | 0.00% | 0.0% |
| Q3 2022 | $357,000 | -25.0% | 147,034 | -38.9% | 0.00% | 0.0% |
| Q2 2022 | $476,000 | +93.5% | 240,611 | +79.0% | 0.00% | – |
| Q1 2022 | $246,000 | +29.5% | 134,425 | -0.4% | 0.00% | – |
| Q4 2021 | $190,000 | +54.5% | 134,949 | +23.8% | 0.00% | – |
| Q3 2021 | $123,000 | +2.5% | 109,037 | +45.5% | 0.00% | – |
| Q2 2021 | $120,000 | -9.8% | 74,957 | -0.6% | 0.00% | – |
| Q1 2021 | $133,000 | +66.2% | 75,410 | +83.9% | 0.00% | – |
| Q4 2020 | $80,000 | -15.8% | 41,002 | +3.0% | 0.00% | – |
| Q3 2020 | $95,000 | -22.1% | 39,800 | -4.6% | 0.00% | – |
| Q2 2020 | $122,000 | -17.0% | 41,725 | +76.1% | 0.00% | -100.0% |
| Q3 2018 | $147,000 | +119.4% | 23,700 | +59.1% | 0.00% | – |
| Q2 2018 | $67,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |